USV has a portfolio of 83 patent submissions for APIs, Finished Dosages and Biosimilars. Of these 30 patents have been granted and 53 submissions are pending approval.
|
Finished Products
|
| |
Granted |
11 |
| |
Pending |
13 |
| |
Total |
24 |
APIs |
| |
Granted |
17 |
| |
Pending |
36 |
| |
Total |
53 |
Synthetic Peptides |
| |
Granted |
1 |
| |
Pending |
4 |
| |
Total |
5 |
Biologics |
| |
Granted |
4 |
| |
Pending |
6 |
| |
Total |
10 |
|
